These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12124802)

  • 21. Terminal deletion of chromosome 3p sequences in nonpapillary renal cell carcinomas: a breakpoint cluster between loci D3S1285 and D3S1603.
    Wilhelm M; Bugert P; Kenck C; Staehler G; Kovacs G
    Cancer Res; 1995 Nov; 55(22):5383-5. PubMed ID: 7585605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detailed deletion mapping of chromosome arm 3p in breast cancers: a 2-cM region on 3p14.3-21.1 and a 5-cM region on 3p24.3-25.1 commonly deleted in tumors.
    Matsumoto S; Kasumi F; Sakamoto G; Onda M; Nakamura Y; Emi M
    Genes Chromosomes Cancer; 1997 Nov; 20(3):268-74. PubMed ID: 9365834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [From identification of genomic polymorphism to diagnostic and prognostic markers of human epithelial tumors].
    Braga EA; Kiselev LL; Zabarovskiĭ ER
    Mol Biol (Mosk); 2004; 38(2):179-90. PubMed ID: 15125222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of heterozygosity on chromosome arms 3p and 6q in microdissected adenocarcinomas of the uterine cervix and adenocarcinoma in situ.
    Acevedo CM; Henríquez M; Emmert-Buck MR; Chuaqui RF
    Cancer; 2002 Feb; 94(3):793-802. PubMed ID: 11857315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3p21, 5q21, and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small-cell lung cancer, while they are unusual in patients with no evidence of malignancy.
    Sanz-Ortega J; Saez MC; Sierra E; Torres A; Balibrea JL; Hernando F; Sanz-Esponera J; Merino MJ
    J Pathol; 2001 Nov; 195(4):429-34. PubMed ID: 11745674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers.
    Geradts J; Fong KM; Zimmerman PV; Maynard R; Minna JD
    Clin Cancer Res; 1999 Apr; 5(4):791-800. PubMed ID: 10213214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mapping allelic deletions on the short arm of human chromosome 3 in kidney neoplasms].
    Bazov IV; Kazubskaia TP; Ermilova VD; Gar'kavtseva RF; Loginov VI; Zabarovskiĭ ER; Braga EA
    Mol Biol (Mosk); 2001; 35(3):404-12. PubMed ID: 11443921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prognostic value of heterozygosity loss in chromosome 3p in non-microcytic bronchogenic carcinoma].
    Maestro ML; Izquierdo L; Sánchez-Pernaute A; Sanz Casla MT; González S; Torres A; del Barco V; Gómez A; Pérez Aguirre E; Balibrea JL
    Med Clin (Barc); 1999 Apr; 112(14):527-9. PubMed ID: 10363238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Methylation of promoter region of RASSF1A gene and frequencies of allelic imbalances in chromosome 3 critical regions are correlated with progression of clear cell renal cell carcinoma].
    Loginov VI; Khodyrev DS; Pronina IV; Kazubskaia TP; Ermilova VD; Gar'kavtseva RF; Braga EA
    Mol Biol (Mosk); 2009; 43(3):429-38. PubMed ID: 19548529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of heterozygosity at chromosome 3p in epithelial ovarian cancer in China.
    Zhang GL; Xu KL
    Int J Gynecol Cancer; 2002; 12(2):198-201. PubMed ID: 11975680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of heterozygosity at chromosomes 3p and 17p in primary non-small cell lung cancer.
    Chmara M; Wozniak A; Ochman K; Kobierska G; Dziadziuszko R; Sosinska-Mielcarek K; Jassem E; Skokowski J; Jassem J; Limon J
    Anticancer Res; 2004; 24(6):4259-63. PubMed ID: 15736482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential deletions of chromosome 3p are associated with the development of uterine cervical carcinoma in Indian patients.
    Dasgupta S; Chakraborty SB; Roy A; Roychowdhury S; Panda CK
    Mol Pathol; 2003 Oct; 56(5):263-9. PubMed ID: 14514919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a 6-cM minimal deletion at 11q23.1-23.2 and exclusion of PPP2R1B gene as a deletion target in cervical cancer.
    Pulido HA; Fakruddin MJ; Chatterjee A; Esplin ED; Beleño N; Martinez G; Posso H; Evans GA; Murty VV
    Cancer Res; 2000 Dec; 60(23):6677-82. PubMed ID: 11118052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers.
    Yu MY; Tong JH; Chan PK; Lee TL; Chan MW; Chan AW; Lo KW; To KF
    Int J Cancer; 2003 Jun; 105(2):204-9. PubMed ID: 12673680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours.
    Agathanggelou A; Honorio S; Macartney DP; Martinez A; Dallol A; Rader J; Fullwood P; Chauhan A; Walker R; Shaw JA; Hosoe S; Lerman MI; Minna JD; Maher ER; Latif F
    Oncogene; 2001 Mar; 20(12):1509-18. PubMed ID: 11313894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
    Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
    Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deletion mapping of chromosome 3p in human uterine cervical cancer.
    Kohno T; Takayama H; Hamaguchi M; Takano H; Yamaguchi N; Tsuda H; Hirohashi S; Vissing H; Shimizu M; Oshimura M
    Oncogene; 1993 Jul; 8(7):1825-32. PubMed ID: 8099726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-density marker analysis of 11p15.5 in non-small cell lung carcinomas reveals allelic deletion of one shared and one distinct region when compared to breast carcinomas.
    Tran YK; Newsham IF
    Cancer Res; 1996 Jul; 56(13):2916-21. PubMed ID: 8674040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma of the oral cavity.
    Wu CL; Sloan P; Read AP; Harris R; Thakker N
    Cancer Res; 1994 Dec; 54(24):6484-8. PubMed ID: 7987846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristic loss of heterozygosity in chromosome 3P and low frequency of replication errors in sporadic renal cell carcinoma.
    Chino K; Esumi M; Ishida H; Okada K
    J Urol; 1999 Aug; 162(2):614-8. PubMed ID: 10411097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.